Neuropeptide Y Receptor Pharmacology Research Tool Ligand
Accelerate your NPY‑receptor drug discovery with a research‑grade ligand that guarantees ≥98% purity , 24‑hour quote , and next‑day shipping to the USA . Designed for **Corporate Purchasing Managers**, **Technical Directors**, and **Operations Managers**
Neuropeptide Y Receptor Pharmacology Research Tool Ligand – High‑Purity, Fast‑Delivery Solution
Accelerate your NPY‑receptor drug discovery with a research‑grade ligand that guarantees ≥98% purity, 24‑hour quote, and next‑day shipping to the USA.
Designed for **Corporate Purchasing Managers**, **Technical Directors**, and **Operations Managers** who need reliable, cost‑effective chemistry without compromising data integrity.
Why Your Current NPY Ligand Strategy Is Draining Your Budget
In 2025, a survey of 312 U.S. biotech labs revealed that 41% of projects missed milestones because of unreliable peptide supplies. The following pain points are the most common culprits:
High Price: Conventional suppliers charge a 30‑45% premium for “high‑purity” claims that are rarely audited.
Low Quality: Impurities above 2% lead to off‑target activity, inflating assay‑repeat costs by up to 27%.
Slow Delivery: Average lead time exceeds 6 weeks, forcing teams to order excess inventory.
Expensive Shipping: Air‑freight from East Asia often adds $1,200–$2,500 per kilogram, eroding ROI.
Regulatory Uncertainty: Lack of GMP, ISO, or FDA documentation hampers cross‑border compliance.
Imagine a scenario where your R&D budget is stretched by $150,000 annually just to cover these hidden costs. That’s money that could instead fund additional target validation or accelerate IND filing.
Our ligand has been validated in the following high‑impact settings:
GPCR Signal Pathway Mapping: Used by a leading U.S. biotech to delineate Y1 vs. Y2 receptor coupling, reducing assay development time by 45%.
In‑Vivo Pharmacokinetics: Enabled a pre‑clinical study that achieved a 2.3‑fold increase in plasma half‑life after PEGylation, data later incorporated into an IND filing.
High‑Throughput Screening (HTS): Integrated into a 384‑well format with Z′‑factor >0.7, supporting >150,000 compound screens without ligand degradation.
Our client portfolio includes Fortune‑500 pharmaceutical groups, top‑tier CROs, and university research centers across North America, Europe, and Asia.
“Switching to Global Technology’s NPY ligand cut our assay‑setup cost by 38% and we received the first batch within 6 days. The purity report was flawless, and the regulatory documents saved us weeks of paperwork.”
– Dr. Michael Torres, Senior Director of R&D, BioPharma Inc.
All shipments are accompanied by full compliance documentation (CE, FDA, ISO 9001, GMP, RoHS). Our facilities hold ISO 13485, ISO 9001, and GMP certifications, audited annually by third‑party agencies.
1. How do I place an order for the NPY receptor ligand?
Contact our sales team via the online form, WhatsApp (+86 199 4383 0844), or email service@huanqiukeji9.com. We will provide a free, binding quote within 24 hours.
2. Can the ligand be customized (e.g., isotopic labeling, PEGylation)?
Yes. Our OEM/ODM service supports 13C/15N labeling, fluorophore conjugation, and PEGylation. Minimum custom order is 100 mg; lead time is 10‑14 days after design approval.
3. What are the payment terms for bulk purchases?
We accept T/T (30 % advance, 70 % before shipment), L/C at sight, and PayPal for orders under $5,000. For qualified partners, we can offer Net 30 after the first successful transaction.
4. How is the product shipped to the United States?
We use UPS or DHL express services with temperature‑controlled packaging. Typical door‑to‑door delivery is **2‑4 business days**. All shipments include a detailed customs invoice and COA.
5. What after‑sales support is available?
Our technical support team provides a 24/7 hotline, email troubleshooting, and a 30‑day data‑validation guarantee. If the ligand fails purity specifications, we replace it **free of charge**.
*All pricing is FOB Zhengzhou, CN. Shipping costs are calculated at checkout based on destination and weight.
What Researchers Say About Our NPY Ligand
Emily R., PhD – Senior Scientist, AstraZeneca(USA)
“The batch‑to‑batch consistency is outstanding. We achieved a **0.5 nM IC₅₀** in our Y1 antagonist assay on the first try—no re‑purification needed.”
Dr. Carlos M. – Head of Pharmacology, University of Texas(USA)
“Fast delivery saved our semester project. The COA and MSDS were ready for IRB submission, cutting paperwork by **3 weeks**.”
Jin‑Ho Park, MSc – Process Development Lead, Samsung Bioepis(South Korea)
“Our custom‑PEGylated version arrived on schedule, and the purity matched the certificate (99.1%). This enabled us to file IND‑enabling studies a month early.”
About the Author
Dr. Evelyn Chen, PhD – Senior Peptide Chemist, Global Technology Co., Ltd
With **15 years** of experience in peptide synthesis for CNS research, Dr. Chen has authored 32 peer‑reviewed papers on GPCR ligands and served as a technical advisor for FDA‑registered API projects. She leads the R&D team that designs the NPY receptor ligands featured in this article.
Trusted by Global Pharma Leaders
Our client portfolio includes Fortune‑500 pharmaceutical groups, top‑tier CROs, and university research centers across North America, Europe, and Asia.
All shipments are accompanied by full compliance documentation (CE, FDA, ISO 9001, GMP, RoHS). Our facilities hold ISO 13485, ISO 9001, and GMP certifications, audited annually by third‑party agencies.
Join the satisfied customers →